Augmented Berlin-Frankfurt-Munster (BFM) Therapy for Adolescent/Young Adults With Acute Lymphoblastic Leukemia or Acute Lymphoblastic Lymphoma

Clinical trial NCT00866749 · COMPLETED

Trial details

NCT number: NCT00866749
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lymphoblastic Leukemia Lymphoblastic Lymphoma

Start date: 2006-09-12
Primary completion: 2018-07-26
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.